SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-11-052400
Filing Date
2011-11-09
Accepted
2011-11-08 18:08:12
Documents
8
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 BIOSPECIFICS TECHNOLOGIES CORP 10-Q 9-30-2011 form10q.htm 10-Q 572878
2 EXHIBIT 31 ex31.htm EX-31 18772
3 EXHIBIT 32 ex32.htm EX-32 7009
  Complete submission text file 0001140361-11-052400.txt   1898151

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bstc-20110930.xml EX-101.INS 204973
5 XBRL SCHEMA DOCUMENT bstc-20110930.xsd EX-101.SCH 12586
6 XBRL CALCULATION LINKBASE DOCUMENT bstc-20110930_cal.xml EX-101.CAL 32928
7 XBRL LABEL LINKBASE DOCUMENT bstc-20110930_lab.xml EX-101.LAB 135857
8 XBRL PRESENTATION LINKBASE DOCUMENT bstc-20110930_pre.xml EX-101.PRE 76154
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 111188971
SIC: 2834 Pharmaceutical Preparations